chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rhinorrhea (a runny nose), oropharyngeal pain (really bad sore throat), got COVID-19, general symptoms (pretty mild symptoms) and really bad headache in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 02SJ202A) for COVID-19 immunization. No medical history reported. On Jan 28, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 28, 2021, patient experienced rhinorrhea (a runny nose), oropharyngeal pain (really bad sore throat), got COVID-19, general symptom (pretty mild symptoms) and really bad headache. On Feb 4, 2021, rhinorrhea (a runny nose), oropharyngeal pain (really bad sore throat), got COVID-19, general symptoms (pretty mild symptoms) and really bad headache resolved. Diagnostic results: On Jan 28, 2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported. This case linked to MOD-2021-089411 (patient link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Muscle spasms, Musculoskeletal stiffness, Nasal congestion, Nausea
Clinical narrative: muscle cramps; congestion; thick sputum; stiff; Nausea; Foot swollen; itchy rash; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle cramps), NASAL CONGESTION (congestion), PRODUCTIVE COUGH (thick sputum), MUSCULOSKELETAL STIFFNESS (stiff) and NAUSEA (Nausea) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (muscle cramps), NASAL CONGESTION (congestion), PRODUCTIVE COUGH (thick sputum), MUSCULOSKELETAL STIFFNESS (stiff), NAUSEA (Nausea), PERIPHERAL SWELLING (Foot swollen), RASH PRURITIC (itchy rash) and DIARRHOEA (diarrhea). At the time of the report, MUSCLE SPASMS (muscle cramps), NASAL CONGESTION (congestion), PRODUCTIVE COUGH (thick sputum), MUSCULOSKELETAL STIFFNESS (stiff), NAUSEA (Nausea), PERIPHERAL SWELLING (Foot swollen), RASH PRURITIC (itchy rash) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient states that she was scheduled to receive her second dose today, but called the customer care center to reschedule her second dose appointment due to these symptoms. no concomitant medications are provided. treatment to the events not reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Productive cough, Rash pruritic
Clinical narrative: muscle cramps; congestion; thick sputum; stiff; Nausea; Foot swollen; itchy rash; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle cramps), NASAL CONGESTION (congestion), PRODUCTIVE COUGH (thick sputum), MUSCULOSKELETAL STIFFNESS (stiff) and NAUSEA (Nausea) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (muscle cramps), NASAL CONGESTION (congestion), PRODUCTIVE COUGH (thick sputum), MUSCULOSKELETAL STIFFNESS (stiff), NAUSEA (Nausea), PERIPHERAL SWELLING (Foot swollen), RASH PRURITIC (itchy rash) and DIARRHOEA (diarrhea). At the time of the report, MUSCLE SPASMS (muscle cramps), NASAL CONGESTION (congestion), PRODUCTIVE COUGH (thick sputum), MUSCULOSKELETAL STIFFNESS (stiff), NAUSEA (Nausea), PERIPHERAL SWELLING (Foot swollen), RASH PRURITIC (itchy rash) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient states that she was scheduled to receive her second dose today, but called the customer care center to reschedule her second dose appointment due to these symptoms. no concomitant medications are provided. treatment to the events not reported.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Fever 101.1; headache; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 101.1), HEADACHE (headache) and FATIGUE (feeling tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced PYREXIA (Fever 101.1), HEADACHE (headache) and FATIGUE (feeling tired). At the time of the report, PYREXIA (Fever 101.1), HEADACHE (headache) and FATIGUE (feeling tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment and concomitant medication reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Incorrect dose administered
Clinical narrative: Needle came apart and vaccine dripped down the arm; Patient got less than half the dose; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (Needle came apart and vaccine dripped down the arm) and INCORRECT DOSE ADMINISTERED (Patient got less than half the dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DEVICE CONNECTION ISSUE (Needle came apart and vaccine dripped down the arm) and INCORRECT DOSE ADMINISTERED (Patient got less than half the dose). Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Apr-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Dizziness, Headache, Pain
Clinical narrative: Arthralgia; Body aches; Rise of blood pressure; Strong Head ache; Body ache; Dizzines; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Rise of blood pressure), HEADACHE (Strong Head ache), PAIN (Body ache), DIZZINESS (Dizzines) and ARTHRALGIA (Arthralgia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (Rise of blood pressure), HEADACHE (Strong Head ache), PAIN (Body ache) and DIZZINESS (Dizzines). On 24-Apr-2021, the patient experienced ARTHRALGIA (Arthralgia) and PAIN (Body aches). At the time of the report, BLOOD PRESSURE INCREASED (Rise of blood pressure), HEADACHE (Strong Head ache), PAIN (Body ache), DIZZINESS (Dizzines), ARTHRALGIA (Arthralgia) and PAIN (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 101f (High) 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided. Concomitant medication not provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration interrupted
Clinical narrative: past 42 days for second dose, has yet to receive 2nd dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (past 42 days for second dose, has yet to receive 2nd dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (past 42 days for second dose, has yet to receive 2nd dose). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (past 42 days for second dose, has yet to receive 2nd dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: FU received on 24-May-21. Both dose batch number mentioned. Second dose details provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Intentional product use issue, Myalgia, Nausea
Clinical narrative: Muscle aches and pains; Bad headache but getting better; Feeling nauseas; "I wont be able to get the 2nd dose due to a family emergency."; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE ("I wont be able to get the 2nd dose due to a family emergency."), MYALGIA (Muscle aches and pains), HEADACHE (Bad headache but getting better) and NAUSEA (Feeling nauseas) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE ("I wont be able to get the 2nd dose due to a family emergency."). On 30-Apr-2021, the patient experienced MYALGIA (Muscle aches and pains), HEADACHE (Bad headache but getting better) and NAUSEA (Feeling nauseas). On 24-Apr-2021, INTENTIONAL PRODUCT USE ISSUE ("I wont be able to get the 2nd dose due to a family emergency.") had resolved. At the time of the report, MYALGIA (Muscle aches and pains), HEADACHE (Bad headache but getting better) and NAUSEA (Feeling nauseas) outcome was unknown. Not Provided          Concomitant medication was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up received on 03-MAY-2021. (2nd Dose) events added. It contains significant information.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Oropharyngeal pain, Productive cough, Pyrexia
Clinical narrative: Cough; Running nose; sore throat; Lots of phlegm; A lot of congestion; Sinus problem; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), COUGH (Cough), RHINORRHOEA (Running nose), OROPHARYNGEAL PAIN (sore throat) and PRODUCTIVE COUGH (Lots of phlegm) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (Fever). On 27-Mar-2021, the patient experienced COUGH (Cough), RHINORRHOEA (Running nose), OROPHARYNGEAL PAIN (sore throat), PRODUCTIVE COUGH (Lots of phlegm), NASAL CONGESTION (A lot of congestion) and SINUSITIS (Sinus problem). At the time of the report, PYREXIA (Fever), COUGH (Cough), RHINORRHOEA (Running nose), OROPHARYNGEAL PAIN (sore throat), PRODUCTIVE COUGH (Lots of phlegm), NASAL CONGESTION (A lot of congestion) and SINUSITIS (Sinus problem) outcome was unknown. Not Provided          no concomitant medications are provided. treatment to the events not reported.   This case was linked to MOD-2021-089374 (Patient Link).
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sinusitis
Clinical narrative: Cough; Running nose; sore throat; Lots of phlegm; A lot of congestion; Sinus problem; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), COUGH (Cough), RHINORRHOEA (Running nose), OROPHARYNGEAL PAIN (sore throat) and PRODUCTIVE COUGH (Lots of phlegm) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (Fever). On 27-Mar-2021, the patient experienced COUGH (Cough), RHINORRHOEA (Running nose), OROPHARYNGEAL PAIN (sore throat), PRODUCTIVE COUGH (Lots of phlegm), NASAL CONGESTION (A lot of congestion) and SINUSITIS (Sinus problem). At the time of the report, PYREXIA (Fever), COUGH (Cough), RHINORRHOEA (Running nose), OROPHARYNGEAL PAIN (sore throat), PRODUCTIVE COUGH (Lots of phlegm), NASAL CONGESTION (A lot of congestion) and SINUSITIS (Sinus problem) outcome was unknown. Not Provided          no concomitant medications are provided. treatment to the events not reported.   This case was linked to MOD-2021-089374 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Headache, Illness
Clinical narrative: weak; sick all over; terrible headache; fever 101F; aches/pain in the back of neck and shoulder; aches/pain in the back of neck and shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (aches/pain in the back of neck and shoulder), ASTHENIA (weak), ILLNESS (sick all over), HEADACHE (terrible headache) and PYREXIA (fever 101F) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CITALOPRAM for Anxiety, ROSUVASTATIN for Cholesterol, PANTOPRAZOLE for Hernia, ATENOLOL, AMLODIPINE and POTASSIUM CHLORIDE for Hypertension, COLECALCIFEROL (VITAMIN D 3) for Supplementation therapy.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced NECK PAIN (aches/pain in the back of neck and shoulder), HEADACHE (terrible headache), PYREXIA (fever 101F) and ARTHRALGIA (aches/pain in the back of neck and shoulder). On 23-Apr-2021, the patient experienced ASTHENIA (weak) and ILLNESS (sick all over). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, qid and ACETYLSALICYLIC ACID (ASPIRINE) for Adverse event, at a dose of UNK, qid. On 17-Apr-2021, NECK PAIN (aches/pain in the back of neck and shoulder), HEADACHE (terrible headache), PYREXIA (fever 101F) and ARTHRALGIA (aches/pain in the back of neck and shoulder) had resolved. On 23-Apr-2021, ASTHENIA (weak) and ILLNESS (sick all over) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 101 (High) fever 101F. On 22-Apr-2021, SARS-CoV-2 test: positive (Positive) COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-274024 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Second dose information was provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: weak; sick all over; terrible headache; fever 101F; aches/pain in the back of neck and shoulder; aches/pain in the back of neck and shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (aches/pain in the back of neck and shoulder), ASTHENIA (weak), ILLNESS (sick all over), HEADACHE (terrible headache) and PYREXIA (fever 101F) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CITALOPRAM for Anxiety, ROSUVASTATIN for Cholesterol, PANTOPRAZOLE for Hernia, ATENOLOL, AMLODIPINE and POTASSIUM CHLORIDE for Hypertension, COLECALCIFEROL (VITAMIN D 3) for Supplementation therapy.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced NECK PAIN (aches/pain in the back of neck and shoulder), HEADACHE (terrible headache), PYREXIA (fever 101F) and ARTHRALGIA (aches/pain in the back of neck and shoulder). On 23-Apr-2021, the patient experienced ASTHENIA (weak) and ILLNESS (sick all over). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, qid and ACETYLSALICYLIC ACID (ASPIRINE) for Adverse event, at a dose of UNK, qid. On 17-Apr-2021, NECK PAIN (aches/pain in the back of neck and shoulder), HEADACHE (terrible headache), PYREXIA (fever 101F) and ARTHRALGIA (aches/pain in the back of neck and shoulder) had resolved. On 23-Apr-2021, ASTHENIA (weak) and ILLNESS (sick all over) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 101 (High) fever 101F. On 22-Apr-2021, SARS-CoV-2 test: positive (Positive) COVID-19 positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-274024 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Second dose information was provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps). At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Joint stiffness, Therapeutic response unexpected
Clinical narrative: A little stiffness around knees after 2nd dose; Can now run, walk and jump after 2nd dose; Improvement in knees since 2nd dose; Very little pain in knees after 2nd dose; Really bad chills after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (A little stiffness around knees after 2nd dose), THERAPEUTIC RESPONSE UNEXPECTED (Can now run, walk and jump after 2nd dose), THERAPEUTIC RESPONSE UNEXPECTED (Improvement in knees since 2nd dose), ARTHRALGIA (Very little pain in knees after 2nd dose) and CHILLS (Really bad chills after 2nd dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020b21a and 044a21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Congestive heart failure and Knee pain since 2014.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT STIFFNESS (A little stiffness around knees after 2nd dose), THERAPEUTIC RESPONSE UNEXPECTED (Can now run, walk and jump after 2nd dose), THERAPEUTIC RESPONSE UNEXPECTED (Improvement in knees since 2nd dose), ARTHRALGIA (Very little pain in knees after 2nd dose) and CHILLS (Really bad chills after 2nd dose). At the time of the report, JOINT STIFFNESS (A little stiffness around knees after 2nd dose), THERAPEUTIC RESPONSE UNEXPECTED (Can now run, walk and jump after 2nd dose), THERAPEUTIC RESPONSE UNEXPECTED (Improvement in knees since 2nd dose), ARTHRALGIA (Very little pain in knees after 2nd dose) and CHILLS (Really bad chills after 2nd dose) outcome was unknown.            No concomitant medications were reported.  The patient reported that the doctors advised her a full knee replacement, but after a few days after administration of the second dose of vaccine, her knee pain and stiffness had reduced and mobility improved.  Treatment information included sleep and liquids. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine),was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: hot around the injection site; it feels hard-some; itchy around the injection site; red spot around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot around the injection site), VACCINATION SITE INDURATION (it feels hard-some), VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red spot around the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B321A) for COVID-19 vaccination.     Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), HYDROCHLOROTHIAZIDE, ALPRAZOLAM (XANAX), PROPRANOLOL, CLONIDINE HCL, ATORVASTATIN CALCIUM (LIPITOR), METFORMIN HCL and VITAMINS NOS for an unknown indication.    On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE WARMTH (hot around the injection site), VACCINATION SITE INDURATION (it feels hard-some), VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red spot around the injection site). The patient was treated with IBUPROFEN for Arthritis, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (hot around the injection site), VACCINATION SITE INDURATION (it feels hard-some), VACCINATION SITE PRURITUS (itchy around the injection site) and VACCINATION SITE ERYTHEMA (red spot around the injection site) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient also took ginger tablets as concomitant medication. Treatment with rubbing alcohol for the itching part at the site of the injection ibuprofen, were provided.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sharp pain (like a pinpoint pain) in the left calf muscle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sharp pain (like a pinpoint pain) in the left calf muscle) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sharp pain (like a pinpoint pain) in the left calf muscle). At the time of the report, PAIN IN EXTREMITY (Sharp pain (like a pinpoint pain) in the left calf muscle) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.     This case was linked to MOD-2021-089542 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Covid infection after first dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid infection after first dose of Moderna vaccine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced COVID-19 (Covid infection after first dose of Moderna vaccine). On 16-Apr-2021, COVID-19 (Covid infection after first dose of Moderna vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Apr-2021, SARS-CoV-2 test: positive (Positive) positive. On 16-Apr-2021, SARS-CoV-2 test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: Unable to use the arm; Excruciating arm pain; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Unable to use the arm) and PAIN IN EXTREMITY (Excruciating arm pain) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0D1BL1A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced LIMB DISCOMFORT (Unable to use the arm) and PAIN IN EXTREMITY (Excruciating arm pain). At the time of the report, LIMB DISCOMFORT (Unable to use the arm) and PAIN IN EXTREMITY (Excruciating arm pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided.  Concomitant medication not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Hypoaesthesia, Injection site induration, Pain in extremity, Pyrexia
Clinical narrative: Arm hurts; Feels numb/sleepy; Feels numb/sleepy; Sharp pain in her chest (That increases with arm movement); Hardness at injection site (for 2 days); Fever (for a day); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), HYPOAESTHESIA (Feels numb/sleepy), SOMNOLENCE (Feels numb/sleepy), CHEST PAIN (Sharp pain in her chest (That increases with arm movement)) and INJECTION SITE INDURATION (Hardness at injection site (for 2 days)) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and LISINOPRIL for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts), HYPOAESTHESIA (Feels numb/sleepy), SOMNOLENCE (Feels numb/sleepy) and CHEST PAIN (Sharp pain in her chest (That increases with arm movement)). On an unknown date, the patient experienced INJECTION SITE INDURATION (Hardness at injection site (for 2 days)) and PYREXIA (Fever (for a day)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm hurts), HYPOAESTHESIA (Feels numb/sleepy), SOMNOLENCE (Feels numb/sleepy) and CHEST PAIN (Sharp pain in her chest (That increases with arm movement)) outcome was unknown and INJECTION SITE INDURATION (Hardness at injection site (for 2 days)) and PYREXIA (Fever (for a day)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Arm hurts; Feels numb/sleepy; Feels numb/sleepy; Sharp pain in her chest (That increases with arm movement); Hardness at injection site (for 2 days); Fever (for a day); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), HYPOAESTHESIA (Feels numb/sleepy), SOMNOLENCE (Feels numb/sleepy), CHEST PAIN (Sharp pain in her chest (That increases with arm movement)) and INJECTION SITE INDURATION (Hardness at injection site (for 2 days)) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and LISINOPRIL for an unknown indication.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts), HYPOAESTHESIA (Feels numb/sleepy), SOMNOLENCE (Feels numb/sleepy) and CHEST PAIN (Sharp pain in her chest (That increases with arm movement)). On an unknown date, the patient experienced INJECTION SITE INDURATION (Hardness at injection site (for 2 days)) and PYREXIA (Fever (for a day)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm hurts), HYPOAESTHESIA (Feels numb/sleepy), SOMNOLENCE (Feels numb/sleepy) and CHEST PAIN (Sharp pain in her chest (That increases with arm movement)) outcome was unknown and INJECTION SITE INDURATION (Hardness at injection site (for 2 days)) and PYREXIA (Fever (for a day)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown. Not Provided          No concomitant medication was provided by the reporter .  Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: Source document received on 9/5/2021 does not contain any new information On 10-May-2021: Source document received on 10/5/2021 does not contain any new information
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Dose from a vial that had been in the refrigerator for more than 2 weeks; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Dose from a vial that had been in the refrigerator for more than 2 weeks) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Dose from a vial that had been in the refrigerator for more than 2 weeks). On 23-Apr-2021, PRODUCT STORAGE ERROR (Dose from a vial that had been in the refrigerator for more than 2 weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pyrexia, Vaccination site pain, Vaccination site swelling
Clinical narrative: Red area; Red hot fever; Pain at the injection site; Left arm swollen (4 inches long and 5 inches wide); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red area), PYREXIA (Red hot fever), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Left arm swollen (4 inches long and 5 inches wide)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21ATCP4 and 008B212ATCP4) for COVID-19 vaccination.     No medical history provided.  The patient's past medical history included Pacemaker insertion (cardiac) (Had a pacemaker put in 3 years ago). Concomitant products included OSEDRATE for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red area), PYREXIA (Red hot fever), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Left arm swollen (4 inches long and 5 inches wide)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Red area), PYREXIA (Red hot fever), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Left arm swollen (4 inches long and 5 inches wide)) outcome was unknown.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (severe diarrhea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Hip deformity NOS. Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced DIARRHEA (severe diarrhea). On 20-Apr-2021, DIARRHEA (severe diarrhea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up information received on 26-MAY-2021, updated patient's relevant history ( hip problem and hypertension) and mentioned she was taking Blood pressure medicine for the past 5-10 years to manage it.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia, Vaccination site rash, Vaccination site warmth
Clinical narrative: Injection site is hot; Rash on her left arm since she received the vaccination but that the rash is getting brighter and; Fever; Chills; Normal sore arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Normal sore arm for a couple of days), VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE RASH (Rash on her left arm since she received the vaccination but that the rash is getting brighter and), PYREXIA (Fever) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN IN EXTREMITY (Normal sore arm for a couple of days), VACCINATION SITE RASH (Rash on her left arm since she received the vaccination but that the rash is getting brighter and), PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site is hot). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 15-Apr-2021, PAIN IN EXTREMITY (Normal sore arm for a couple of days), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, VACCINATION SITE WARMTH (Injection site is hot) and VACCINATION SITE RASH (Rash on her left arm since she received the vaccination but that the rash is getting brighter and) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Vaccine expiration date was given as 01Jan1900.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: fever; Flu like symptoms; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Apr-2021 and was forwarded to Moderna on 24-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cataracts. Concomitant products included LOSARTAN and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and PYREXIA (fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included HRT implant called BioTe and the patient is scheduled for a Pap Smear.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Seasonal allergy
Clinical narrative: experiencing seasonal allergies after receiving the second dose in the series; This spontaneous case was reported by a consumer and describes the occurrence of SEASONAL ALLERGY (experiencing seasonal allergies after receiving the second dose in the series) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pollen allergy (seasonal allergies to pollen), Seasonal allergy (seasonal allergies to trees) and Grass allergy (seasonal allergies to grass). Concomitant products included CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ZYRTEC-D) for Seasonal allergy, ASCORBIC ACID (VITAMIN C ACID) and ZINC for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced SEASONAL ALLERGY (experiencing seasonal allergies after receiving the second dose in the series). At the time of the report, SEASONAL ALLERGY (experiencing seasonal allergies after receiving the second dose in the series) had not resolved.            No Treatment information provided
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of headache in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 0071A21A) for COVID-19 immunization. No medical history reported. On Apr 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 23, 2021, patient experienced headache. At the time of the report, headache outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported/provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Bedridden, Feeling abnormal, Influenza like illness, Myalgia
Clinical narrative: flu like symptoms; feeling bad; in bed all day; feeling of sore muscles; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feeling bad), BEDRIDDEN (in bed all day) and MYALGIA (feeling of sore muscles) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feeling bad), BEDRIDDEN (in bed all day) and MYALGIA (feeling of sore muscles). On 15-Mar-2021, INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feeling bad), BEDRIDDEN (in bed all day) and MYALGIA (feeling of sore muscles) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.    This case was linked to MOD-2021-089348 (Patient Link).
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Somnolence
Clinical narrative: very tired; sleeping a lot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (very tired) and SOMNOLENCE (sleeping a lot) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, the patient experienced FATIGUE (very tired) and SOMNOLENCE (sleeping a lot). At the time of the report, FATIGUE (very tired) and SOMNOLENCE (sleeping a lot) outcome was unknown. Not Provided          No concomitant medications were provided. No treatment drugs were reported. Crosslinked with case MOD21-081439
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: fatigue; soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and VACCINATION SITE PAIN (soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) and CLONAZEPAM for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced FATIGUE (fatigue) and VACCINATION SITE PAIN (soreness). At the time of the report, FATIGUE (fatigue) and VACCINATION SITE PAIN (soreness) outcome was unknown.      Treatment details were not provided  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.